Markets Gone Wild

Investigation Launched Against STAAR Surgical Company: What Does This Mean for Investors and the World? On March 1, 2025, Levi & Korsinsky, a leading securities law firm, announced the initiation of an investigation into STAAR Surgical Company (STAA) regarding potential violations of federal securities laws. The investigation comes in response to the company’s disappointing fourth-quarter…

Johnson & Johnson’s Icotrokinra Achieves Clinical Remission Rates up to 30.2% in Phase 2b ANTHEM-UC Study In a recent press release, Johnson & Johnson (J&J) announced positive topline results from the Phase 2b ANTHEM-UC study of icotrokinra (JNJ-2113), an investigational targeted oral peptide that selectively blocks the IL-23 receptor. The study was conducted in adults…

Y-mAbs Therapeutics: Exciting Times Ahead as They Unveil Q4 and Full Year 2024 Results New York, NY – In an exhilarating turn of events, Y-mAbs Therapeutics, Inc. (YMAB), a pioneering biopharmaceutical company specializing in the development and commercialization of innovative radioimmunotherapies and antibody-based therapeutic products for cancer treatment, has announced that they will be sharing…

Heineken Holding N.V. Announces First Tranche of Share Buyback Programme Press Release Amsterdam, 13 February 2025 – Heineken Holding N.V. Heineken Holding N.V. has recently made an exciting announcement regarding its share buyback programme. This move reflects the company’s confidence in its financial position and its ongoing commitment to delivering value to shareholders. The first…

Understanding the Securities Lawsuit Against Constellation Brands, Inc. (STZ) On February 27, 2025, a securities class action lawsuit was filed against Constellation Brands, Inc. (NYSE: STZ) in the United States District Court for the Southern District of New York. The complaint alleges that the company and certain of its executives violated the federal securities laws…